PLoS ONE (Jan 2012)

p21 as a transcriptional co-repressor of S-phase and mitotic control genes.

  • Nuria Ferrándiz,
  • Juan M Caraballo,
  • Lucía García-Gutierrez,
  • Vikram Devgan,
  • Manuel Rodriguez-Paredes,
  • M Carmen Lafita,
  • Gabriel Bretones,
  • Andrea Quintanilla,
  • M Jose Muñoz-Alonso,
  • Rosa Blanco,
  • Jose C Reyes,
  • Neus Agell,
  • M Dolores Delgado,
  • G Paolo Dotto,
  • Javier León

DOI
https://doi.org/10.1371/journal.pone.0037759
Journal volume & issue
Vol. 7, no. 5
p. e37759

Abstract

Read online

It has been previously described that p21 functions not only as a CDK inhibitor but also as a transcriptional co-repressor in some systems. To investigate the roles of p21 in transcriptional control, we studied the gene expression changes in two human cell systems. Using a human leukemia cell line (K562) with inducible p21 expression and human primary keratinocytes with adenoviral-mediated p21 expression, we carried out microarray-based gene expression profiling. We found that p21 rapidly and strongly repressed the mRNA levels of a number of genes involved in cell cycle and mitosis. One of the most strongly down-regulated genes was CCNE2 (cyclin E2 gene). Mutational analysis in K562 cells showed that the N-terminal region of p21 is required for repression of gene expression of CCNE2 and other genes. Chromatin immunoprecipitation assays indicated that p21 was bound to human CCNE2 and other p21-repressed genes gene in the vicinity of the transcription start site. Moreover, p21 repressed human CCNE2 promoter-luciferase constructs in K562 cells. Bioinformatic analysis revealed that the CDE motif is present in most of the promoters of the p21-regulated genes. Altogether, the results suggest that p21 exerts a repressive effect on a relevant number of genes controlling S phase and mitosis. Thus, p21 activity as inhibitor of cell cycle progression would be mediated not only by the inhibition of CDKs but also by the transcriptional down-regulation of key genes.